Tissue of Origin: Lung
Cancer Type: Lung Squamous Cell Carcinoma
SK-LC-08 is a human lung cancer cell line.
This cell line was established from a lung metastasis from a patient with lung squamous cell carcinoma.
- Lloyd J. Old, MD, former William E. Snee Chair in Cancer Immunology, MSK; former Director of the Ludwig Institute for Cancer Research
PubMed=6208122; DOI=10.1089/hyb.1.1982.1.139 Anger B.R., Lloyd K.O., Oettgen H.F., Old L.J. Mouse monoclonal IgM antibody against human lung cancer line SK-LC-3 with specificity for H(O) blood group antigen. Hybridoma 1:139-147(1982)
This cell line may be licensed nonexclusively for research or commercial purposes.
For internal research purposes by a commercial entity: Utilize MSK’s Express License, attached here. In order to streamline and expedite the licensing of select MSK cell lines, the terms of this non-exclusive license are non-negotiable. Please note: This license is only available for select cell lines, including this one.
To proceed, please download this contract, fill in all relevant fields, and email a scanned version to [email protected]. Once this license has been executed by MSK, you will receive a signed copy and invoice, and can then place your order with ATCC.
For licensing requests for a commercial purpose: Contact MSK’s Tangible Materials team at [email protected].
For non-licensing requests from academic-research institutions: Contact Frances Weis-Garcia, PhD, Associate Laboratory Member/Head, Antibody & Bioresource Core Facility, MSK, 646-888-2354, [email protected].